End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
- PMID: 31069957
- PMCID: PMC6506690
- DOI: 10.1002/jia2.25283
End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
Abstract
Introduction: Adherence to HIV prevention methods is a challenge, particularly for young women in Sub-Saharan Africa. End-user research during product development can inform modifiable factors to increase future uptake and adherence.
Methods: Preferences for four vaginally inserted placebo HIV prevention methods were assessed among Zimbabwean and South African young women using a crossover clinical design. For each of months 1 to 4, participants were asked to use a pre-coitally inserted film, insert (vaginal tablet) and gel once/week for a month, and a monthly ring in a randomly assigned sequence. Participants subsequently chose one preferred product to use as directed for the final study month. Women ranked the four products from most preferred to least preferred at enrolment and after trying all products.
Results: A total of 200 women aged 18 to 30 (mean 23) were enrolled; 178 (89%) completed follow-up. At baseline, 41% of participants selected the gel as their most preferred product and 61% selected the ring as least preferred. During the crossover period, most (82% to 85%) self-reported using each product at least once a week, although only half the time with sex. Objective biomarker data confirmed adequate use of all products. After trying each product, rankings changed with the film, ring, insert and gel being selected by 29%, 28%, 26% and 16% respectively. Choice varied significantly by country (p < 0.001): More Zimbabweans chose the film (45%), and more South Africans chose the insert (34%). Among women choosing the ring, 88% reported using it every time with sex. By contrast, self-reported adherence was lower for "on-demand" (coitally associated) products, with 40% to 55% using them every time during sex (p < 0.001).
Conclusions: Preferences for these four dosage forms varied before and after use, and both within and across countries - there was no clear favourite - indicating the need for a range of options for end-users The ring's popularity increased the most with use, was the second most preferred delivery system, and per self-report, provided more coverage during sex. These end-user perspectives provide important information to product developers and funding agencies.
Keywords: PrEP; South Africa; Zimbabwe; adolescents; microbicides; women.
© 2019 RTI International. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Figures
Similar articles
-
Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.AIDS Behav. 2020 Feb;24(2):637-647. doi: 10.1007/s10461-019-02576-8. AIDS Behav. 2020. PMID: 31254190 Free PMC article. Clinical Trial.
-
Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.J Int AIDS Soc. 2016 May 30;19(1):20875. doi: 10.7448/IAS.19.1.20875. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27247202 Free PMC article.
-
Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S222-S229. doi: 10.1097/QAI.0000000000002215. J Acquir Immune Defic Syndr. 2019. PMID: 31764258
-
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).PLoS One. 2023 Jun 23;18(6):e0287525. doi: 10.1371/journal.pone.0287525. eCollection 2023. PLoS One. 2023. PMID: 37352296 Free PMC article. Clinical Trial.
-
Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.Front Reprod Health. 2023 May 31;5:1156864. doi: 10.3389/frph.2023.1156864. eCollection 2023. Front Reprod Health. 2023. PMID: 37325244 Free PMC article.
Cited by
-
Topical Inserts: A Versatile Delivery Form for HIV Prevention.Pharmaceutics. 2019 Aug 1;11(8):374. doi: 10.3390/pharmaceutics11080374. Pharmaceutics. 2019. PMID: 31374941 Free PMC article. Review.
-
Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.AIDS Behav. 2020 Feb;24(2):637-647. doi: 10.1007/s10461-019-02576-8. AIDS Behav. 2020. PMID: 31254190 Free PMC article. Clinical Trial.
-
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.J Int AIDS Soc. 2021 Jun;24(6):e25747. doi: 10.1002/jia2.25747. J Int AIDS Soc. 2021. PMID: 34118115 Free PMC article. Clinical Trial.
-
A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts.PLOS Glob Public Health. 2025 Mar 31;5(3):e0004081. doi: 10.1371/journal.pgph.0004081. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40163475 Free PMC article.
-
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice.Curr HIV/AIDS Rep. 2024 Oct;21(5):282-292. doi: 10.1007/s11904-024-00704-1. Epub 2024 Jul 24. Curr HIV/AIDS Rep. 2024. PMID: 39046639 Free PMC article. Review.
References
-
- UNAIDS . Fast‐Track: ending the AIDS epidemic by 2030. Geneva: UNAIDS; 2014.
-
- Peters A, Jansen W, van Driel F. The female condom: the international denial of a strong potential. Reprod Health Matters. 2010;18(35):119–28. - PubMed
-
- AVAC . PrEP Watch 2018. [cited 2018 May 21]. Available from: www.prepwatch.org
-
- AVAC . PrEP Watch 2018. [cited 2018 Jan 3]. Available from: www.prepwatch.org
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous